Anzeige
Mehr »
Samstag, 28.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Technology

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
DiNavamedic signs agreement to acquire dne pharma
DiHims & Hers shares plummet 35% as Novo Nordisk pulls partnership plug
DiFDA genAI reviews hinge on clarity of dossiers
DiFDA approves AstraZeneca and Daiichi Sankyo's Datroway for NSCLC
MoBayer's Eylea market grip set to slip as Alvotech biosimilar closes in
MoHarbour BioMed partners Otsuka on new T-cell therapy
MoBridging the gap: A comprehensive approach to social determinants of health
MoEC approves argenx's efgartigimod alfa for CIDP treatment
MoFrom discovery to delivery: making therapies reach patients faster
20.06.Madrigal poised to enter European MASH market after CHMP endorsement
20.06.London Biotechnology Show 2025: Novo Nordisk harnesses AI/ML to accelerate drug development landscape
20.06.Podcast: Uses of blockchain in healthcare
20.06.Novartis' ribociclib approved in Canada for early breast cancer
20.06.FDA cell and gene therapy director exit increases 'volatility' for sector
20.06.NSW government invests $13.39m in life-changing therapies
20.06.DoH - Abu Dhabi and Sanofi link for vaccine development
19.06.CNS innovator oligonucleotide licensing value up 339% from £2bn in 2024
19.06.UK and US governments pursue contrasting vaccine strategies
19.06.Actio gains $66m to advance small molecule therapeutics pipeline
19.06.BioOrbit eyes 2026 for pre-clinical trials of space manufactured protein crystals
19.06.Eli Lilly and Eisai's Alzheimer's drugs denied NHS use due to high costs
19.06.Draig secures $140m for neuropsychiatric disorder therapies
19.06.Gilead Sciences' Yeztugo receives approval from US FDA for HIV
18.06.Bavarian Nordic nets $160m from priority review voucher sale
18.06.Tisento's MELAS treatment receives fast track status from FDA